Steatotic liver disease is part of a revised nomenclature to replace the term fatty liver disease, but this should also drive forward innovation in research, diagnostics and treatments.
References
Rinella, M. E. et al. Ann. Hepatol. 29, 101133 (2023).
Rinella, M. E. et al. Hepatology 78, 1966–1986 (2023).
Rinella, M. E. et al. J. Hepatol. 79, 1542–1556 (2023).
Ludwig, J. et al. Mayo. Clin. Proc. 55, 434–438 (1980).
Eslam, M. et al. J. Hepatol. 73, 202–209 (2020).
Israelsen, M. et al. Lancet Gastroenterol. Hepatol. 8, 866–868 (2023).
Rasmussen, D. N. et al. J. Hepatol. 75, 1017–1025 (2021).
Sanyal, A. J. et al. N. Engl. J. Med. 385, 1559–1569 (2021).
Kim, R. G. et al. Clin. Gastroenterol. Hepatol. 15, 1521–1530.e8 (2017).
Vilar-Gomez, E. et al. Clin. Gastroenterol. Hepatol. 19, 136–145.e6 (2021).
European Society for Paediatric Gastroenterology & European Association for the Study of the Liver. Lancet Gastroenterol. Hepatol. 8, 598–600 (2023).
Gines, P. et al. Lancet 398, 1359–1376 (2021).
European Association for the Study of the Liver. J. Hepatol. 75, 659–689 (2021).
Kjaergaard, M. et al. J. Hepatol. 79, 277–286 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.K. has served as a speaker for Novo Nordisk, Norgine, Siemens and Nordic Bioscience, has participated in advisory boards for Norgine, Siemens, Resalis Therapeutics, Boehringer Ingelheim and Novo Nordisk, all outside the submitted work, has received research support from Norgine, Siemens, Nordic Bioscience, Astra and Echosens, and is a a board member and co-founder of Evido. M.E.R. serves as a scientific consultant to Novo Nordisk, Boehringer Ingelheim, Intercept, CytoDyn, Histoindex, NGM Bio, GSK, Sonic Incytes, Histoindex and Madrigal.
Rights and permissions
About this article
Cite this article
Krag, A., Rinella, M.E. Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction. Nat Med 30, 933–936 (2024). https://doi.org/10.1038/s41591-024-02849-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-02849-3
- Springer Nature America, Inc.
This article is cited by
-
Envisioning how to advance the MASH field
Nature Reviews Gastroenterology & Hepatology (2024)